Kidney Int. 2012 Sep;82(5):511-3. doi: 10.1038/ki.2012.161.
Many end-stage renal disease patients receive thrice-weekly hemodialysis (HD) and report impairments in health-related quality of life (HRQOL). Recent studies indicate that short daily HD may improve HRQOL. High-quality studies exploring the burdens and costs to patients, caregivers, and society are necessary before widespread adoption can be advocated. Further research exploring the mechanisms by which these benefits are realized is also important, as many patients are likely to opt out of short daily HD.
许多终末期肾病患者接受每周三次的血液透析（HD）治疗，并报告称其健康相关生活质量（HRQOL）受损。最近的研究表明，短期每日 HD 可能会改善 HRQOL。在广泛推广之前，有必要进行高质量的研究，以探讨患者、护理人员和社会的负担和成本。进一步研究这些益处实现的机制也很重要，因为许多患者可能会选择退出短期每日 HD。
